Age of asthma onset does not impact the response to omalizumab.

IF 3.5 3区医学 Q2 RESPIRATORY SYSTEM

Chronic Respiratory Disease Pub Date : 2023-01-01 DOI:10.1177/14799731231159673

Linda Rogers, Cecile Tj Holweg, Hooman Pazwash, Jinnie Ko, Samuel Louie

引用次数: 0

Abstract

Trial registration: These studies were conducted before clinical trial registration was required; therefore, clinical trial registration numbers are not available.

Abstract Image

查看原文本刊更多论文

哮喘发病年龄不影响对奥玛珠单抗的反应。

试验注册:这些研究是在需要临床试验注册之前进行的;因此，临床试验注册号不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chronic Respiratory Disease RESPIRATORY SYSTEM-

CiteScore

5.90

自引率

7.30%

发文量

审稿时长

11 weeks

期刊介绍： Chronic Respiratory Disease is a peer-reviewed, open access, scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.